188 related articles for article (PubMed ID: 17090195)
21. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
[TBL] [Abstract][Full Text] [Related]
22. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.
Wang YC; Iezza G; Zuraek MB; Jablons DM; Theodore PR; Bergsland EK; Donner DB; Warren RS; Nakakura EK
J Surg Res; 2010 Sep; 163(1):47-51. PubMed ID: 20599218
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal carcinoid tumors: factors that predict outcome.
Van Gompel JJ; Sippel RS; Warner TF; Chen H
World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
[TBL] [Abstract][Full Text] [Related]
24. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
Kirshbom PM; Kherani AR; Onaitis MW; Feldman JM; Tyler DS
Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
26. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.
Ortiz-Rey JA; Alvarez C; San Miguel P; Iglesias B; Antón I
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin expression in small intestinal and appendiceal carcinoids. A basis for classification.
Wilander E; Scheibenpflug L
Acta Oncol; 1993; 32(2):131-4. PubMed ID: 7686762
[TBL] [Abstract][Full Text] [Related]
28. Specific methods for detection of 5-hydroxytryptamine in carcinoid tumors.
Enerbäck L
Virchows Arch A Pathol Pathol Anat; 1973; 358(1):35-43. PubMed ID: 4630874
[No Abstract] [Full Text] [Related]
29. Demonstration of CDX2 is highly antibody dependant.
Borrisholt M; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):64-72. PubMed ID: 22595949
[TBL] [Abstract][Full Text] [Related]
30. Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids.
Kuiper P; Verspaget HW; Biemond I; de Jonge-Muller ES; van Eeden S; van Velthuysen ML; Taal BG; Lamers CB
J Endocrinol Invest; 2011 Oct; 34(9):665-70. PubMed ID: 21060250
[TBL] [Abstract][Full Text] [Related]
31. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
32. The use of Alu-PCR to distinguish between typical pulmonary carcinoids versus classic midgut carcinoids.
Furmaga WB; Cole SR; Tsongalis GJ
Int J Oncol; 2004 Jan; 24(1):223-6. PubMed ID: 14654961
[TBL] [Abstract][Full Text] [Related]
33. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794
[TBL] [Abstract][Full Text] [Related]
34. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
35. Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum.
Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A
Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817
[TBL] [Abstract][Full Text] [Related]
36. Subepithelial neuroendocrine cells and carcinoid tumours of the human small intestine and appendix. A comparative immunohistochemical study with regard to serotonin, neuron-specific enolase and S-100 protein reactivity.
Lundqvist M; Wilander E
J Pathol; 1986 Feb; 148(2):141-7. PubMed ID: 3512805
[TBL] [Abstract][Full Text] [Related]
37. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
Altree-Tacha D; Tyrrell J; Haas T
Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
[TBL] [Abstract][Full Text] [Related]
38. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
Cathro HP; Mills SE
Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
[TBL] [Abstract][Full Text] [Related]
40. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES
Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]